Topical Advisory Panel for section 'Leukemias'

Please see the section webpage for more information on this section.

Members


Website
Lady Davis Institute, Jewish General Hospital, McGill University, Montreal, QC, Canada
Interests: clinical trials; leukemia; lymphoma; novel targeted monoclonal antibody therapies; proteasome inhibitors; histone deacetylase inhibitors; drugs targeting protein translation

Website
Department of Leukemia, the University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
Interests: acute myelogenous leukemia; myelodysplastic syndrome; autophagy; epigenetic targets; BRD4

Website
Haematology and Stem Cell Transplant Unit, Department of Biomedicine and Prevention, University of Rome ‘Tor Vergata’, 00133 Rome, Italy
Interests: clinical hematology; acute leukemias; acute myeloid leukemia; immunophenotyping of hematological malignancies; allogeneic transplantation; measurable residual disease by flow cytometry and molecular techniques
Special Issues, Collections and Topics in MDPI journals
The Ohio State University Comprehensive Cancer Center, 455 Wiseman Hall, 410 West 12th Avenue, Columbus, OH 43210, USA
Interests: chronic lymphocytic leukemia; acute myeloid leukemia; myelodysplastic syndrome; pre-clinical and early clinical drug development; precision medicine

Website
Department of Leukemia, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
Interests: acute myeloid leukemia (AML); myelodysplastic syndrome (MDS); bone marrow aspiration; bone marrow transplant
Special Issues, Collections and Topics in MDPI journals

Website
Department of Hematology, University Medical Center Groningen, University of Groningen, 9713 GZ Groningen, The Netherlands
Interests: acute myelogenous leukemia; myelodysplastic syndrome; ageing; clonal hematopoiesis; allogeneic HCT

grade Website
Department of Leukemia, the University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
Interests: acute leukemias; BCL-2; leukemic microenvironment and metabolism; clinical trials; BCL-2 inhibitor venetoclax; inhibitor of oxidative phosphorylation; CXCR4 inhibitors; AKT and mTOR inhibitors; hypoxia-activated prodrugs
Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada
Interests: endothelial differentiation; acute myeloid leukemia (AML); gene therapy; hemophilia; hematopoiesis

Website
M Subklewe, Department of Medicine III, University Hospital, LMU Munich, Marchioninistr. 15, D‐81377 München, Germany
Interests: acute myelogenous leukemia; immunotherapy; bispecific antibody constructs; CAR T; flow MRD; dendritic cell vaccination; leukemia associated target antigens

Website
Department of Haematology, Alfred Health, 55 Commercial Road, Prahran, Melbourne, VIC 3004, Australia
Interests: acute myeloid leukaemia; azacytidine; BH3; Bcl-2; lenalidomide; leukaemia foundation; lymphoma; Mcl-1; relapse and refractory; clinical AML; leukaemic stem cells; translational AML

Website
Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, IL, USA
Interests: leukemia; blood & bone marrow disorders; chronic myelogenous leukemia; myeloproliferative; neoplasms; acute myeloid leukemia; myelodysplastic syndromes; aplastic anemia

Website
Departments of Laboratory Medicine and Pathology, University of Washington, Seattle, WA 98195, USA
Interests: acute leukemia; MRD; residual disease; flow cytometry; NGS
Back to TopTop